Minimum Effective Dosages of Anti-TNF in Rheumatoid Arthritis: A Cross-sectional Study Inmaculada de la Torre, Lara Valor, Juan Carlos Nieto, María Montoro, Luis Carreño

Pattern of use and safety of non-steroidal anti-inflammatory drugs in rheumatoid arthritis patients. A prospective analysis from clinical practice Iván Ferraz-Amaro, Machin, Loreto Carmona, Gonzalez-Alvaro, Diaz-Gonzalez

Is the use of secukinumab after anti-TNF therapy greater than expected for the risk of developing inflammatory bowel disease? Fatih Albayrak, Mustafa Gür, Ahmet Karataş, Süleyman Serdar Koca, Bünyamin Kısacık